Emergent BioSolutions has announced only two acquisitions in the past 5 years. 

With the acquisition of Trubion, Emergent BioSolutions strengthened its oncology product pipeline and also broadened its monoclonal antibody therapeutic capabilities.

With its strategic acquisition of Cangene recently in December 2013, Emergent Biosolutions accelerated its biodefense portfolio by adding marketed therapeutics.

The company looks to enter into M&A agreements for licensed marketed products to expand their business in specialty markets.

Abstracted from:  Partnering Agreements with Emergent BioSolutions 2009-2014

View the full details of the deals at Current Agreements (subscription required)

Emergent BioSolutions M&A at Current Agreements

View all M&A deals for Emergent BioSolutions: 2014 | 2013 | 2012 | 2011 | 2010 | 2009

Full details on each deal can be found at CurrentAgreements (subscription required)

More   

Summary profile data for Emergent BioSolutions

Partnering interests for Emergent BioSolutions

Partnering activity for Emergent BioSolutions                     

Related reports from Current Partnering

Report:  Partnering Agreements with Emergent BioSolutions 2009-2014

Report:  Partnering Deals and Alliances with Big Biotech

Report: Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics

Available resources for deal coverage for Emergent BioSolutions

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Emergent BioSolutions company profile, recent partnering, M&A and financing news and articles

Related

Report: Finding Biopharma Licensing and Collaboration Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter